.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Baxter
Johnson and Johnson
Daiichi Sankyo
Deloitte
Moodys
UBS
Covington
Chinese Patent Office

Generated: September 19, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Process and solvate of 2-methyl-thieno-benzodiazepine
Abstract:The invention provides lower alcohol solvates of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine (olanzapine) and a process for making such lower alcohol solyates of olanzapine. The invention provides a method for using such solyates of olanzapine to prepare substantially pure anhydrous Form I 2-methyl-thieno-benzodiazepine.
Inventor(s): Bunnell; Charles A. (Lafayette, IN), Hotten; Terrence M. (Farnborough, GB2), Larsen; Samuel D. (West Lafayette, IN), Tupper; David E. (Reading, GB2)
Assignee: Eli Lilly and Company (Indianapolis, IN) Lilly Industries Limited (Basingstoke, GB2)
Filing Date:Mar 24, 1995
Application Number:08/410,474
Claims:1. A crystalline mono methanol solvate form of a compound of the Formula I ##STR3##

2. A crystalline mono ethanol solvate form of a compound of the Formula I ##STR4##

3. A crystalline mono 1-propanol solvate form of a compound of the Formula I ##STR5##

4. A process for preparing a lower alcohol solvate comprising preparing technical olanzapine which comprises contacting intermediate 1 ##STR6## with dimethylsulfoxide and N-methylpiperazine with heating at about 90.degree. C. to about 130.degree. C.; and

crystallizing olanzapine from the reaction mixture with a solvent selected from the group consisting of lower alcohols to provide the corresponding lower alcohol solvate of olanzapine.

5. A method of claim 4 wherein the lower alcohol is methanol.

6. A method of claim 4 wherein the lower alcohol is ethanol.

7. A method of claim 4 wherein the lower alcohol is 1-propanol.

8. A method of claim 4 further comprising converting the resulting lower alcohol solvate into olanzapine.

9. A method of claim 8 wherein olanzapine is substantially pure Form I.

10. A method of claim 8 wherein the lower alcohol solvate is the methanolate.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Daiichi Sankyo
Baxter
Moodys
QuintilesIMS
Cantor Fitzgerald
Johnson and Johnson
McKesson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot